Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-11-04
2008-08-05
Whisenant, Ethan (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S024300
Reexamination Certificate
active
07407759
ABSTRACT:
The present invention provides new probes for the detection of prostate cancer cells. The probes bind selectively with target polynucleotide sequences selected from the group consisting of 2q, 4q, 5q, 6q, 10p, 15q, 1q, 2p, 3q, 3p, 4q, 6p, 7p, 7q, 9q, 11p, 16p, and 17q.
REFERENCES:
patent: 5344760 (1994-09-01), Harvey et al.
patent: 5427910 (1995-06-01), Kamentsky et al.
patent: 5472842 (1995-12-01), Stokke et al.
patent: 5506106 (1996-04-01), Croce et al.
patent: 5552277 (1996-09-01), Nelson et al.
patent: 5658730 (1997-08-01), McGill et al.
patent: 5925519 (1999-07-01), Jensen et al.
patent: 6451529 (2002-09-01), Jensen et al.
patent: 0954607 (1997-05-01), None
patent: WO 97/46702 (1997-12-01), None
Cher et al., Comparative Genomic Hybridization, Allelic imbalance, and Fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes, Chromosomes & Cancer 11 : 153-162 (1964).
Cher et al., Genetic Alterations in untreated metastases and androgen -independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Research 56:3091-3102 (Jul. 1996).
Kallioniemi et al., Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 : 818-821 (1992).
Macoska et al. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 insdtability in human prostate cancer. Cancer Research 54 : 3824-3830 (1994).
Macoska et al., Extensive genetic alterations in prostate cancer revealed by dual PCR and Fish analysis. Genes Chromosomes and Cancer 8 : 88-97(1993).
Matsuyama et al. Deletion mapping of chromosome 8 in prostate cancer by fluorescence in situ hybridization. Oncogene 9 : 3071-3076 (1994).
Visakorpi et al. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am. J. of Pathology 145(3) : 624-630 (1994).
Visakorpi et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Research 55 : 342-347 (1995). (1994).
Sidney et al. Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer amonh blacks and whites in a prepaid health care plan. Am. J. of Epidemiology 134(8) : 825-829 (1991).
Arps et al., Cancer Genetics & Cytogenetics 66(2) : 93-99 (1993).
Bergerheim, U.S.R. et al. “Deletion Mapping of Chromosomes 8, 10, and 16 in Human Prostatic Carcinoma” Genes, Chromosomes & Cancer 3:215-220(1991).
Bova et al., Cancer Research 53:3869-3873 (1993).
Bowcock et al., Science 258:73 (1992).
Brothman et al., Cancer Research 50:3796-3803 (1990).
Carter, B.S. et al., “Allelic loss of chromosomes 16q and 10q in human prostate cancer” Proc. Natl. Acad. Sci. USA 87:8751-8755 (1990).
Chang, M. et al., “Short Communication: Deletion Mapping of Chromosome 8p in Colorectal Carcinoma and Dysplasia Arising in Ulcerative Colitis, Prostatic Carcinoma, and Malignant Fibrous Histiocytomas” American Journal of Pathology 144:1-6 (1994).
Cher et al., “Mapping Regions of Physical Deletion on Chromosome 16q in Prostate Cancer Cells by Fluorescence in situ Hybridization (Fish)” The Journal of Urology 153:249-254 (Jan. 1995).
Cher, M.L. et al. “Comparative Genomic Hybridization, Allelic Imbalance, and Flourescence In Situ Hybridization on Chromosome 8 in Prostate Cancer” Genes, Chromosomes & Cancer 11:153-162 (1994).
Cher, M.L. et al. “Mapping of Regions of Physical Deletion on Chromosome 16q in Prostate Cancer Cells by Fluorescence In Situ Hybridization (Fish)” The Journal of Urology 153:249-254 (1995).
Cher, M.L. et al. “Genetic Alterations in Untreated Metastases and Androgen-independent Prostate Cancer Detected by Comparative Genomic Hybridization and Allelotyping”; 1996, Cancer Research, vol. 56, pp. 3091-3102.
DeGeorges et al., International Journal of Cancer 62:724-731 (Sep. 1995).
Goffman et al., Cancer Genetics and Cytogenetics 8(3):197-202 (1993).
Hasketh, R., “The Oncogene Handbook”, p. 493, Academic Press, San Diego, CA (1994).
Joos et al., “Mapping of Chromosomal Gains and Losses in Prostate Cancer by Comparative Genomic Hybridization” Genes, Chromosomes & Cancer 14:267-276 (Jan. 1995).
Kallionemi et al., PNAS 89:5321-5325 (1992).
Kallioniemi, A. et al.; “Comparative Genomin Hybridization for Molecular Cytogenetic Analysis of Solid Tumors”; 1992, Science, vol. 258, pp. 818-821.
Kunimi, K. et al. “Allelotyping of Human Prostatic Adenocarcinoma” Genomics 11:530-536 (1991).
Latil, A. et al. “Genetic Alterations in Localized Prostate Cancer: Identification of a Common Region of Deletion on Chromosome Arm 18q” Genes, Chromosomes & Cancer 11:119-125 (1994).
Lundegren et al., Genes, Chromosomes & Cancer 4:16-24 (1992).
Ma et al., Human Genetics 96(6) : 731-735 (Dec. 1995).
MacGrogan, D. et al. “Loss of Chromosome Arm 8p Loci in Prostate Cancer: Mapping by Quantitative Allelic Imbalance” Genes, Chromosomes & Cancer 10:151-159 (1994).
Macoska et al. “Extensive Genetic Alterations in Prostate Cancer Revealed by Dual PCR and Fish Analysis” Gene, Chromosomes & Cancer 8:88-97 (1993).
Macoska et al. “Fluoresence in situ Hybridization analysis of 8p Loss and Chromosome 8 Instability in Human Prostate Cancer” Cancer Research 54:3824-3830.
Massenkeil, G. et al. “P53 Mutations and Loss of Heterozygosity on Chromosomes 8p, 16p, 17p, and 18q are Confined to Advanced Prostate Cancer” Anticancer Research 14:2789-2794 (1994).
Matsuyama, Hideyasu et al.; “Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization”; 1994, Oncogene, vol. 9, No. 10, pp. 3071-3076.
Morton et al. “Reduction of E-Cadherin Levels and Detection of the Alpha-Catenin Gene in Human Prostate Cancer Cells” Cancer Research 53:3585-3590 (Aug. 1993).
The Oncor Catalog, p. 17 (1992/1993 Edition).
Phillips, S.M.A. et al. “Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer” British Journal of Urology 73:390-395 (1994).
Ransom et al., Genes Chromosomes & Cancer 5:75-82 (1992).
Rasheed et al., Genes Chromosomes & Cancer 5:348-256 (1992).
Sakr, W.A. et al. “Allelic Loss in Locally Metastatic, Multisampled Prostate Cancer” Cancer Research 54:3273-3277 (1994).
The Stratagene Catalog, p. 39 (1988).
Suzuki, H. et al. “Localization of a Tumor Suppressor Gene Associated With Progression of Human Prostate Cancer Within a 1.2 Mb Region of 8p22-p21.3” Genes, Chromosomes & Cancer 13:168-174 (1995).
Trapman, J. et al. “Loss of Heterozygosity of Chromosome 8 Microsatellite Loci Implicates a Candidate Tumor Suppressor Gene between the Loci D8S87 and D8S133 in Human Prostate Cancer” Cancer Research 54:6061-6064 (1994).
Trybus et al., Cancer Research 56(10):2263-2267 (May 1996).
Visakorpi, T. et al. “Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization”; 1994,American Journal of Pathology, vol. 145, No. 3, pp. 624-630.
Visakorpi, T. et al. “Genetic Changes in Primary and Recurrent Prostate Cancer by Comparative Genomic Hybridization” Cancer Research 55:342-347 (1995).
White et al., American J. of Medical Genetics 56(1):101-105 (1995).
Williams et al., Cancer Genetics and Cytogenetics 85:143-152 (Dec. 1995).
Zenklusen et al., Cancer Research 54:6370-6373 (1994).
Cher Michael L.
Jensen Ronald H.
The Regents of the University of California
Townsend and Townsend / and Crew LLP
Whisenant Ethan
LandOfFree
Genetic alterations associated with prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic alterations associated with prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic alterations associated with prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4005532